Oxytocin-augmented Cognitive-behavioral Group-based Short-term Intervention for Loneliness

NCT04137432 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Loneliness

Interventions

DRUG: Oxytocin nasal spray
DRUG: Placebo

Sponsor

University Hospital, Bonn

Collaborators

[object Object]
[object Object]